FDA Approves Mydayis
FDA Approves Mydayis (mixed salts of a single-entity amphetamine product) – A New Once-Daily Option for ADHD

FDA Approves Mydayis (mixed salts of a single-entity amphetamine product) – A New Once-Daily Option for ADHD
FRIDAY, June 16, 2017 -- The best present you can give your dad this Fathers Day is to help him get healthy, according to a doctor specializing in mens health. "We tend to think men dont want to talk about their own health, but I find thats really not
FRIDAY, June 16, 2017 -- Relax your mind and then consider this: The physical and mental health benefits of pursuits like yoga and meditation begin in your genes, a new review suggests. The researchers reviewed 18 studies, involving a total of 846 peop
June 8, 2017 -- Today, the U.S. Food and Drug Administration requested that Endo Pharmaceuticals remove its opioid pain medication, reformulated Opana ER (oxymorphone hydrochloride), from the market. After careful consideration, the agency is seeking remo
DUBLIN--(BUSINESS WIRE)--Jun. 6, 2017-- Alkermes plc (NASDAQ: ALKS) today announced that the U.S. Food and Drug Administration (FDA) has approved two-month Aristada (aripiprazole lauroxil) extended-release injectable suspension for the treatment of schizo
FRIDAY, June 2, 2017 -- For people who battled cancer in childhood, the prospects for a long life without cancer recurrence or chronic illness are better than ever, a new study finds.Thats largely due to changes in cancer treatment protocols that have